To cite this paper use one of the standards below:
Cubosomes have emerged as a powerful platform for cancer treatment due to their biocompatibility and their ability to encapsulate both hydrophilic and lipophilic drugs, providing controlled drug release.1,2 While investigating their stability and intracellular localization is essential for advancing these nanoparticles as clinically effective nanomedicines, such studies are still lacking.1,3,4 In this study, we address these aspects for phytantriol and monoolein cubosomes (≈200 nm). Colloidal stability assays in biological media showed that both nanoparticles remained stable for 24 hours, which is crucial for ensuring their internalization into target cells. Regarding intracellular localization, the most commonly used techniques are conventional fluorescence microscopy, confocal microscopy, and transmission electron microscopy. However, these methods often either fail to provide a complete overview of the cellular context or suffer from limited penetration depth, necessitating sample sectioning and involving chemical treatments or laborious cryogenic workflows.5 To overcome these limitations, we conducted a pioneering study using a combination of correlative high-resolution three-dimensional fluorescence microscopy and soft X-ray tomography (a synchrotron-based technique) at cryogenic
temperatures, leveraging natural cellular contrast. Remarkably, these analyses revealed that cubosomes were present around the nucleus, specifically within lysosomes. This study is crucial not only for advancing the therapeutic potential of cubosomes but also for defining the intracellular localization of other nanoparticles in greater detail using synchrotron-based 3D imaging techniques. Additionally, we incorporated doxorubicin into phytantriol and monoolein cubosomes and evaluated their toxicity against healthy (BJ-5Ta, fibroblasts) and tumor cells (MDA-MB-231, breast cancer cells). Both nanoparticles exhibited lower toxicity toward healthy cells compared to tumor cells, a fundamental characteristic for safer and more efficient use in nanomedicine.
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2017/26131-5 and 2022/02378-0) and iNEXT-Discovery (Diamond Light Source, UK – process 26687).
(1) Angew. Chem. 2019, 58, 2958–2978.
(2) ACS Appl Mater Interfaces 2024, 16, 12161–12174.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper